Suscribirse para recibir un email cada vez que se introduzca un ítem en esta colección.

Vista previa	Fecha de publicación	Fecha de Creación	Título
	oct-2024	-	La reconstrucción posmastectomía y su relación con la radioterapia adyuvante en el tratamiento del cáncer invasivo de mama: ¿asunto cerrado?
	15-may-2024	-	AEOL-Induced NRF2 Activation and DWORF Overexpression Mitigate Myocardial I/R Injury
	may-2024	-	Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
	14-abr-2024	-	Anticipating the side effects of benznidazole: HLA-B*35 and patch test
	13-ene-2024	-	Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer
	oct-2023	-	Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis
	22-sep-2023	-	Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia
	sep-2023	-	Circulating ST2, from biomarker to pathogenic mediator
	1-ago-2023	-	HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19
	4-jul-2023	-	EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci
	4-jul-2023	-	EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci
	1-jun-2023	-	Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized tria
	17-may-2023	-	GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
	may-2023	-	Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
	2023	-	Tolerance and adherence of patients with chronic chagas disease treated with benznidazole
	2023	-	The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
	2023	-	Clinical and demographic features of HIV infection in El Salvador
	2023	-	Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
	2023	-	Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
	3-dic-2022	-	Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study